Repligen (RGEN) Non Operating Interest Expenses (2011 - 2026)
Repligen's (RGEN) quarterly Non Operating Interest Expenses came in at $5.7 million in Q2 2026, up 5.77% year-over-year from $5.4 million in Q2 2025, and up 1.52% quarter-over-quarter from $5.6 million in Q1 2026.
Analysis
Repligen (RGEN) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non Operating Interest Expenses for 16 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses rose 5.77% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $22.2 million, a 4.54% increase from a year earlier, with the FY2025 full-year figure at $21.5 million, up 3.77% from the prior year.
- Non Operating Interest Expenses was $5.7 million for Q2 2026 at Repligen, up from $5.6 million in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $5.7 million in Q2 2026 and troughed at $270000.0 in Q4 2022.
- A 5-year average of $3.2 million and a median of $5.1 million in 2024 frame the typical range for Non Operating Interest Expenses.
- Across the five-year window, Non Operating Interest Expenses tumbled 90.62% in 2022 and soared 1155.39% in 2024, its largest moves.
- Over 5 years, Non Operating Interest Expenses stood at $270000.0 in 2022, then jumped by 372.59% to $1.3 million in 2023, then jumped by 328.06% to $5.5 million in 2024, then climbed by 0.6% to $5.5 million in 2025, then increased by 3.06% to $5.7 million in 2026.
- The last three Non Operating Interest Expenses figures came in at $5.7 million (Q2 2026), $5.6 million (Q1 2026), and $5.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.83 Bn | 220.76 Bn | 8.34 Bn | 401.00 Mn |
| 2 | Danaher | 144.59 Bn | 140.24 Bn | 3.61 Bn | 107.00 Mn |
| 3 | Agilent Technologies | 40.99 Bn | 39.23 Bn | 1.04 Bn | 29.00 Mn |
| 4 | Illumina | 31.27 Bn | 30.10 Bn | 770.00 Mn | 24.00 Mn |
| 5 | Revvity | 13.86 Bn | 12.83 Bn | 416.87 Mn | 25.79 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 2.12 Mn |
| 7 | Bio-Rad Laboratories | 10.09 Bn | 8.47 Bn | 345.80 Mn | 12.10 Mn |
| 8 | Repligen | 9.30 Bn | 8.28 Bn | 110.04 Mn | 5.66 Mn |
| 9 | 10x Genomics | 8.63 Bn | 8.08 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.29 Bn | 8.08 Bn | 416.00 Mn | 17.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.66 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 5.50 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 5.46 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 408,000.00 |
| Jun 30, 2023 | 411,000.00 |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 270,000.00 |
| Sep 30, 2022 | 329,000.00 |
| Jun 30, 2022 | 271,000.00 |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 2.88 Mn |
| Sep 30, 2021 | 2.86 Mn |